| Date Filed | Type | Description |
| 08/16/2023 |
4
| Sinclair Andrew (Director) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Disposed/sold 28,828 options to buy
@ $15.75, valued at
$454k
Granted 28,828 options to buy
@ $0
Disposed/sold 18,500 options to buy
@ $15.93, valued at
$294.7k
Granted 18,500 options to buy
@ $0
Disposed/sold 8,172 options to buy
@ $15.93, valued at
$130.2k
Granted 8,172 options to buy
@ $0
Disposed/sold 18,500 options to buy
@ $11.49, valued at
$212.6k
Disposed/sold 26,400 options to buy
@ $5.195, valued at
$137.1k
Granted 26,400 options to buy
@ $0 |
|
| 06/02/2023 |
4
| Sinclair Andrew (Director) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Granted 5,900 shares
@ $0
Granted 26,400 options to buy
@ $5.195, valued at
$137.1k
|
|
| 05/26/2023 |
4
| Sinclair Andrew (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 2,666 options to buy
@ $5.03, valued at
$13.4k
Granted 10,000 options to buy
@ $5.25, valued at
$52.5k
|
|
| 10/14/2022 |
4
| Sinclair Andrew (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC |
| 10/14/2022 |
4
| Sinclair Andrew (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 2,666 options to buy
@ $0 |
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2022 |
4
| Sinclair Andrew (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Bought 7,720,000 shares
@ $0
Bought 7,720,000 warrants
@ $0.3, valued at
$2.3M
|
|
| 02/01/2022 |
4
| Sinclair Andrew (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Bought 150,000 shares
@ $27, valued at
$4.1M
Exercised (in-or-at-the-money) 287,471 options to buy
@ $13.2, valued at
$3.8M
|
|
| 12/13/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2021 |
4
| Sinclair Andrew (Director) has filed a Form 4 on Verona Pharma plc|
Txns:
| Granted 64,000 options to buy
@ $0 |
|
| 06/09/2021 |
4
| Sinclair Andrew (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 6,000 options to buy
@ $18.11, valued at
$108.7k
|
|
| 06/04/2021 |
4
| Sinclair Andrew (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 31,862 options to buy
@ $1.02, valued at
$32.5k
|
|
| 03/16/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/16/2021 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 03/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 01/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2020 |
4
| Sinclair Andrew (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 6,874 options to buy
@ $13.98, valued at
$96.1k
|
|
| 05/20/2020 |
4
| Sinclair Andrew (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 9,530 options to buy
@ $3.41, valued at
$32.5k
|
|
| 02/03/2020 |
4/A
| Sinclair Andrew (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Converted 871,240 shares
@ $0
Converted 11,500 options to buy
@ $0 |
|
| 01/31/2020 |
4
| Sinclair Andrew (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Converted 871,125 shares
@ $0
Converted 11,500 options to buy
@ $0 |
|
| 12/03/2019 |
4
| Sinclair Andrew (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 60,000 options to buy
@ $0.3467, valued at
$20.8k
|
|
| 11/26/2019 |
3
| Sinclair Andrew (Director) has filed a Form 3 on Sierra Oncology, Inc. |
| 10/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2019 |
4
| Sinclair Andrew (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 13,000 options to buy
@ $2.5, valued at
$32.5k
|
|
| 12/27/2018 |
4
| Sinclair Andrew (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Bought 4,669,272 shares
@ $1.6, valued at
$7.5M
Bought 4,669,272 warrants
@ $2, valued at
$9.3M
Granted 20,000 options to buy
@ $1.57, valued at
$31.4k
|
|
| 12/27/2018 |
3
| Sinclair Andrew (Director) has filed a Form 3 on SOLENO THERAPEUTICS INC |